Enjoin Strengthens Leadership Team to Accelerate Market Expansion

Enjoin Strengthens Leadership Team to Accelerate Market Expansion-01

Enjoin, a physician-directed mid-revenue cycle solutions provider, announced today expansion of its executive leadership team to include Peder Christensen as the company’s Chief Revenue Officer (CRO). Peder will lead all aspects of the company’s sales, business development, and strategic partnerships with a focus on growth in Enjoin’s solutions portfolio and geographic markets.

This announcement is on the heels of the recent press statement announcing Justin C. Schmidt as Co-CEO. “This is an exciting time of growth for Enjoin and we are excited to have Peder join our team. His extensive background in consultative sales for both services and workforce solutions as well as technology aligns perfectly with our growth trajectory as we strengthen our offerings to support a total solution in mid-revenue cycle including expansion of Enjoin’s pre-bill review and staffing services,” said Justin.

Also Read: Leveraging Cloud Hosting for Effective Ecommerce Marketing

According to Co-CEO James P. Fee, MD, CCS, CCDS, Peder’s experience in service, staffing and technology makes him the ideal person to help lead Enjoin through our next stage of growth and tech-enabled services. “Bringing Peder on board will allow us to scale our sales efforts while staying in tune with the ever-evolving demands and needs of the market we serve,” said Dr. Fee. “In addition, his commitment to client satisfaction and building collaborative client partnerships complements Enjoin’s well established reputation and history of long-term client relationships. We are very pleased he has joined our team.”

With over 15 years of business development and sales management experience, Peder will lead the Sales division, focusing on new markets and revenue opportunities. “I’m thrilled to be a part of Enjoin, especially now, given the market opportunity to deliver high value, quality solutions to support the mid-revenue cycle,” said Peder. “I strongly believe in Enjoin’s portfolio including its highly successful pre-bill review program as a market differentiator.” Formerly, Peder played a key role in business development at Nym, a digital technology company supporting advanced artificial intelligence platform for medical coding and clinical documentation integrity.  Prior to Nym, he led sales efforts at AMN Revenue Cycle Solutions (previously Peak Health Solutions and MedPartners).

For more such updates follow us on Google News TalkCMO News. Subscribe to our Newsletter for more update